Interview with InDex about the publication of the phase IIb CONDUCT study results in the Lancet Gastroenterology and Hepatology

October 6, 2020

CEO Peter Zerhouni, CMO Dr. Thomas Knittel and biostatistician Jan Kowalski comment on the data published in the Lancet Gastroenterology and Hepatology.